Business Context and Reporting Period
This Form 6-K filing by Prudential plc (the "Company") covers the month of September 2025, with the report dated September 8, 2025. Prudential is a global provider of life and health insurance and asset management services, primarily operating in Greater China, ASEAN, India, and Africa. The Company maintains dual primary listings on the Hong Kong Stock Exchange and the London Stock Exchange.
Key Financial Metrics
This filing reports on a specific share repurchase transaction rather than comprehensive financial performance. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
| Metric | Value |
|---|---|
| Transaction Date | September 5, 2025 |
| Shares Purchased | 275,696 |
| Lowest Price Paid | £9.7320 |
| Highest Price Paid | £9.8840 |
| Average Price Paid | £9.7964 |
| Shares Outstanding Post-Transaction | 2,570,161,174 |
Material Changes
The primary material change reported is the reduction of the Company's share capital through the cancellation of repurchased shares. Following the transaction, the total number of voting rights in the Company stands at 2,570,161,174. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of specific risks and contingencies. The transaction was executed in accordance with shareholder authority granted at the 2025 Annual General Meeting and complies with the Listing Rules of the London Stock Exchange and the Hong Kong Code on Share Buy-Backs.
Investor Verification Checklist
- Verify the total number of shares outstanding (2,570,161,174) for disclosure threshold calculations under FCA rules.
- Confirm the execution of the repurchase via Merrill Lynch International as an on-exchange transaction.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular pricing analysis.
- Note that this filing does not contain financial results; refer to the Company's Form 20-F or interim reports for revenue and profit data.